China Economic Net, Beijing, March 31st, the Shenzhen Municipal Market Supervision Administration website recently released the administrative penalty decision “One Health Industry (Shenzhen) Co., Ltd. Case of Giving Prescription Drugs or Class A OTC Drugs Through Tying Sales” ” (Shenzhen Jianlong Punishment [2022] Ji No. 51) shows that One Health Industry (Shenzhen) Co., Ltd. has illegal drug behavior.
According to Article 40 of the “Measures for the Supervision and Administration of Drug Circulation”, the Longgang Supervision Bureau of the Shenzhen Market Supervision Administration “Where pharmaceutical production and distribution enterprises violate the provisions of Article 20 of these Measures, they shall make corrections within a time limit and issue a warning; If the correction is not made within the time limit or the circumstances are serious, a fine of less than 2 times the value of the gifted medicines, but a maximum of 30,000 yuan will be imposed.”
According to the official website, One Health was established in 2014 and is headquartered in Guangzhou. It is a comprehensive health platform enterprise integrating health product research and development, production, sales and service. Since its establishment, OneHealth has continued to expand its business layout, and successively launched business sectors such as “Health Management Center”, “One State Home Edition APP”, “One Health Pharmacy”, “Healthy Smart Equipment”, and plans to develop “Physical Examination Center” and “National Medical Center”. “Internet Hospital” and other business sections. In the future, One Health will continue to provide customers with more comprehensive and detailed health management services.
The reporter of China Economic Net found that Yibang Health Industry (Shenzhen) Co., Ltd. is a wholly-owned subsidiary of Yibang Health Industry Group Co., Ltd., and Yibang Health Industry Group Co., Ltd. is Guangdong Yibang Health Industry Group Co., Ltd. A wholly-owned subsidiary of the Group Co., Ltd., the largest shareholder of Guangdong One Health Industry Group Co., Ltd. is Youchuang Investment Co., Ltd., with a shareholding ratio of 83.93%. Guangdong One Health Industry Group Co., Ltd., formerly known as “Green Thin Health Industry Group Co., Ltd.”, will be renamed in November 2021.
Article 40 of the “Measures for the Supervision and Administration of Drug Circulation” stipulates that if a pharmaceutical production or distribution enterprise violates the provisions of Article 20 of these Measures, it shall make corrections within a time limit and be given a warning; if it fails to make corrections within the time limit or the circumstances are serious, it shall be punished A fine of less than 2 times the value of the drug is given, but the maximum is not more than 30,000 yuan.
The following is the original text:
